NAT1 Antikörper (AA 672-830)
-
- Target Alle NAT1 Antikörper anzeigen
- NAT1 (N-Acetyltransferase 1 (Arylamine N-Acetyltransferase) (NAT1))
-
Bindungsspezifität
- AA 672-830
- Reaktivität
- Human, Maus, Ratte, Rind (Kuh), Hund
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser NAT1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunofluorescence (IF)
- Kreuzreaktivität
- Maus, Ratte (Rattus), Hund, Rind (Kuh)
- Produktmerkmale
-
1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
4. Source of all serum proteins is from USDA inspected abattoirs located in the United States. - Aufreinigung
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
- Immunogen
- Human NAT1 aa. 672-830
- Klon
- 35-T1
- Isotyp
- IgG1
- Top Product
- Discover our top product NAT1 Primärantikörper
-
-
- Kommentare
-
Related Products: ABIN968535, ABIN967389
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 250 μg/mL
- Buffer
- Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store undiluted at -20° C.
-
-
A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation." in: Molecular and cellular biology, Vol. 20, Issue 2, pp. 496-506, (2000) (PubMed).
: "A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme." in: Genes & development, Vol. 11, Issue 3, pp. 321-33, (1997) (PubMed).
: "
-
A novel form of DAP5 protein accumulates in apoptotic cells as a result of caspase cleavage and internal ribosome entry site-mediated translation." in: Molecular and cellular biology, Vol. 20, Issue 2, pp. 496-506, (2000) (PubMed).
-
- Target
- NAT1 (N-Acetyltransferase 1 (Arylamine N-Acetyltransferase) (NAT1))
- Andere Bezeichnung
- NAT1 (NAT1 Produkte)
- Synonyme
- AAC1 antikoerper, MNAT antikoerper, NAT-1 antikoerper, NATI antikoerper, Nat-1 antikoerper, Nat antikoerper, NAT1 antikoerper, AT-I antikoerper, N-acetyltransferase 1 antikoerper, N-acetyl transferase 1 antikoerper, N-acetyltransferase 1 (arylamine N-acetyltransferase) antikoerper, arylamine N-acetyltransferase 1-like antikoerper, NAT1 antikoerper, Nat1 antikoerper, LOC101095575 antikoerper
- Hintergrund
-
EIF-4 proteins are required for recognition of mRNA and acceleration of protein translation. This group of proteins consists of the RNA helicase eIF-4A, the RNA-binding protein eIF-4B, the cap-binding protein eIF-4E, and eIF-4G (p220). NAT1 (Novel APOBEC-1 Target no. 1), also known as DAP-5 (Death Associated Protein -5), is homologous to eIF-4G. Amino acid sequence comparison of NAT1 and eIF-4 shows that NAT1 lacks an eIF-4G N-terminal region. This region mediates eIF-4G association with eIF-4E. The highest degree of homology is within the central portions of NAT1 and eIF-4G, while the lowest degree of homology occurs at the C-terminus. NAT1 more closely resembles a cleaved form of eIF-4G that is involved in cap-independent translation. It is thought that NAT1 is involved in the repression of translation via its inhibition of both cap-dependent and cap-independent translation.
Synonyms: Novel APOBEC-1 Target no. 1, DAP-5, Death Associated Protein -5 - Molekulargewicht
- 100 kDa
-